Tue, Oct 08, 2024
The company which started operations in India in 2008, currently has 8 manufacturing sites, including 5 in Ahmedabad with additional sites in Dahej, Hyderabad and Vizag, and commercial offices in Mumbai.
More >
Fri, Mar 08, 2024
Pharma company Supriya Lifescience expects to double its revenue to Rs 1,000 crore in the next three years by venturing into higher-margin earning niche segments next fiscal, a senior company executive has said.
Tue, Nov 29, 2022
The shares were disposed of at an average price of Rs 920 apiece, taking the transaction value to Rs 117 crore.
Mon, Nov 07, 2022
Shares of Cipla Ltd (NSE: CIPLA) corrected in the D street on Nov 7. The downtrend follows despite the third-largest pharma company in India reporting a consolidated net profit increase of 12%.
Wed, Sep 28, 2022
How is the new acquisition of Torrent Pharma-Curatio Health Care? How good is the new acquisition for Torrent Pharma? What will happen at Torrent Pharma today after the new acquisition? Know from Anil Singhvi.
Sat, Jul 09, 2022
Sitaglyn and Siglyn offer an oral solution to the patients providing ease of convenience and better compliance, the company said in a regulatory filing.
Tue, Jun 28, 2022
Pharma company Cipla has agreed to acquire an additional stake for nearly Rs 26 crore in digital tech company GoApptiv Private to raise its shareholding to 22.02 per cent, the company said on Monday.
Sat, May 28, 2022
Consolidated revenues of the drug firm, however, rose to Rs 3,019 crore in the quarter under review as compared to Rs 2,860 crore in the year-ago period.
Wed, May 11, 2022
Cipla Share Price:Brokerages are bullish on the Cipla shares and expects a 28 per cent upside in this stock. A healthy March quarter results will likely act as a trigger for the upside, they opined.
Mon, Mar 14, 2022
Several brokerages are betting big on Cipla Limited stocks on the back of robust fundamentals, strong product pipeline in US and improved business outlook. They see an upside of up to 15 per cent in the stock price and find the current valuations attractive.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
